![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
WESTPORT, Conn., April 12, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy...
WESTPORT, Conn., March 26, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy...
WESTPORT, Conn., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG) (βPortageβ or the βCompanyβ), a clinical-stage immuno-oncology company advancing novel multi-targeted...
Prioritize the adenosine clinical candidates iNKT clinical development paused to focus resourcesCompany will evaluate range of strategic options WESTPORT, Conn., Jan. 04, 2024 (GLOBE NEWSWIRE...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0537 | -23.4908136483 | 0.2286 | 0.325 | 0.163 | 2581089 | 0.20884194 | CS |
4 | -0.1091 | -38.4154929577 | 0.284 | 0.3252 | 0.163 | 796331 | 0.22397876 | CS |
12 | -0.3151 | -64.306122449 | 0.49 | 0.54 | 0.163 | 556185 | 0.27868183 | CS |
26 | -1.1451 | -86.75 | 1.32 | 1.39 | 0.163 | 287603 | 0.31937036 | CS |
52 | -3.2051 | -94.825443787 | 3.38 | 3.95 | 0.163 | 154907 | 0.45542447 | CS |
156 | -22.0451 | -99.2128712871 | 22.22 | 23.99 | 0.163 | 70606 | 2.92537709 | CS |
260 | -37.3251 | -99.5336 | 37.5 | 44.9763 | 0.163 | 67380 | 4.53376248 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions